Project Grant R03MH135363

Award Date 8/1/24
Completion Date 7/31/26
Dollars Obligated $157K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This Cooperative Agreement award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, is focused on developing an approach to rapidly match individuals with treatment-resistant depression to the most effective treatment - either accelerated repetitive transcranial magnetic stimulation (rTMS) or ketamine. The $2,754,722 two-year project aims to use machine learning methods to optimize "neuroimaging biomarkers" that can...
This $968,769 Project Grant award from the National Institute of Mental Health (NIMH) under CFDA Program 93.242 (Mental Health Research Grants) will fund a study on the efficacy of maintenance repetitive transcranial magnetic stimulation (rTMS) treatment for individuals with treatment-resistant depression (TRD). The study aims to investigate the ability of two forms of maintenance rTMS - standard and clustered - to sustain functional connectivity between the dorsolateral prefrontal cortex and...
This Project Grant award of $777,016.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to investigate the synaptic mechanisms underlying the effects of continuous theta burst stimulation (cTBS), a form of repetitive transcranial magnetic stimulation (rTMS), in the treatment of depression. The research, to be conducted by The Mclean Hospital Corporation, a nonprofit psychiatric teaching hospital affiliated...
This $514,178 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a study to investigate the mechanistic relationship between brain circuit function and negative valence system behaviors in treatment-resistant depression. The project aims to use low-intensity focused ultrasound (LIFU) neuromodulation to determine how connectivity between the thalamus and prefrontal cortical regions (orbitofrontal and anterior...
This R01 grant award of $784,096 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is funding a research project at The Leland Stanford Junior University to develop optimized methods for measuring brain excitability in depression using repetitive transcranial magnetic stimulation (rTMS). The key objectives are to: 1) investigate how adjusting rTMS parameters affects neural activity measured with intracranial EEG, 2) optimize the...
This federal Project Grant award of $176,979 from the National Institute of Mental Health (NIMH) under CFDA program 93.242 - Mental Health Research Grants supports research to develop personalized neuromodulation approaches to target dysregulated motivational responses underlying social avoidance behavior in patients with major depressive disorder (MDD) or social anxiety disorder (SAD). The key objectives are to use transcranial magnetic stimulation (TMS) to causally modulate patient-specific...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $198,728 to investigate how repetitive transcranial magnetic stimulation (rTMS) affects glutamate signaling and functional connectivity in the salience network to improve treatment for major depressive disorder. The research aims to use cutting-edge 7T neuroimaging techniques, including glutamate chemical exchange saturation transfer...
The federal Project Grant award, titled "CORTICAL INHIBITION AS A BIOMARKER OF RESPONSE IN A COMPARISON OF BILATERAL VERSUS UNILATERAL ACCELERATED THETA BURST STIMULATION FOR SUICIDAL IDEATION IN TREATMENT-RESISTANT DEPRESSION -COMBAT-SI", is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $197,576 award, with a period of performance from September 1, 2024 to August 31, 2029, will support research conducted...
This federal Project Grant award, titled "Elucidating Reward Network Modulation in Medial Forebrain Bundle Deep Brain Stimulation for Treatment Resistant Depression", is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $638,872 award supports a 5-year research project at The Feinstein Institutes for Medical Research to identify metabolic and functional imaging changes in the reward network that correlate with...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to advance transcranial magnetic stimulation (TMS) technologies for psychiatric disorders. The $439,416 award to the Regents of the University of Minnesota will fund a research project to validate a closed-loop approach for prefrontal TMS, where real-time electroencephalographic (EEG) recordings are used to inform the timing of TMS stimulation....

The National Institute of Mental Health (NIMH) awarded a $156,500 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Emory University to identify patients with true treatment failure for major depressive disorder (MDD) who may benefit from earlier referral to alternative treatments like transcranial magnetic stimulation, ketamine, and vagus nerve stimulation.

The project aims to use trajectory classification methods to empirically separate partial response from true treatment failure in patients who do not respond to first-line therapies like SSRIs, SNRIs, and CBT. This will help identify a group of patients more likely to have treatment-resistant depression (TRD) who could then be targeted for earlier referral to alternative treatments. The study will also demonstrate an analytic framework for future modeling of treatment failure using genetic biomarkers. The award period is from August 1, 2024 to July 31, 2026.

Generated 7/1/25, 5:03 AM